Empowering Research Through Patient Engagement
At iRecruitCeliac, we are committed to accelerating the development of treatments for celiac disease to enhance the quality of life for those adhering to a medically necessary gluten-free diet. Through our targeted services and proprietary iQualifyCeliac platform, we offer unparalleled engagement with patients diagnosed with celiac disease, ensuring your study enrolls efficiently and retains participants effectively. Our customizable and flexible solutions are designed to save you time and resources, making us a trusted partner for sponsors, CROs, and sites aiming to successfully enroll and retain celiac disease patients in clinical trials and studies.
For more than 30 years, the Celiac Disease Foundation has led the global effort to advance celiac disease research, secure federal funding, and champion patient rights. Our team brings unmatched expertise in patient engagement, powered by proprietary digital platforms and trusted partnerships with research institutions and advocacy groups worldwide.
In 2018, we launched iQualifyCeliac, a protocol-driven recruitment platform designed to accelerate enrollment and reduce costs. With a growing database of more than 32,000 patients interested in trial participation, iQualifyCeliac delivers real-time, study-matched leads directly to research sites, helping sponsors and CROs reach enrollment goals faster and more efficiently.
We also maintain iCureCeliac, the largest publicly accessible celiac disease registry, with over 16,000 participants across 90+ countries contributing patient-reported data to advance real-world research.
These platforms, together with the team behind them, are redefining what’s possible in celiac disease research. We invite you to partner with us to accelerate the path to treatment and a cure.